By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Drugs used in alcohol dependence > Disulfiram > Disulfiram Dosage
Drugs used in alcohol dependence
https://themeditary.com/dosage-information/disulfiram-dosage-10223.html

Disulfiram Dosage

Drug Detail:Disulfiram (Disulfiram [ dye-sul-fi-ram ])

Drug Class: Drugs used in alcohol dependence

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Alcohol Dependence

  • Initial dose: 500 mg orally once a day (this dose is generally continued for the first 1 to 2 weeks)
  • Maintenance dose: 250 mg orally once a day (range: 125 mg to 500 mg once a day)
Maximum dose: 500 mg once a day
  • Duration of therapy: Depending on the individual, therapy may last months or even years

Comment:
  • Although usually taken in the morning, this drug may be dosed in the evening by patients who experience a sedative effect. Also, the dosage may be adjusted downward.

Use: An alcohol deterrent in the treatment of carefully selected and cooperative patients with drinking problems; its use should be accompanied by appropriate supportive treatment.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

  • Following the initial treatment period (6 weeks to 6 months), therapy should be reevaluated for efficacy prior to continuing with a more prolonged treatment.
  • The initial dose may be decreased to minimize the sedative effect.

Precautions

US BOXED WARNING:

  • This drug should never be administered to a patient when he is in a state of alcohol intoxication, or without his full knowledge.
  • The physician should instruct relatives accordingly.

Safety and efficacy have not been established in patients younger than 18 years

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Administration with food may increase the bioavailability of this drug.
  • This drug should not be administered until the patient has abstained from alcohol for at least 24 hours.
  • This drug is preferably administered in the morning; however, in patients who experience sedation, it may be given at bedtime.

General:
  • Therapy with this drug should only be considered as part of an integrated program including counseling and psychiatry.
  • Patients who stop therapy should be advised to wait at least 1 week before taking alcohol and that reactions with alcohol may occur for up to 3 weeks after terminating therapy.
  • Trial with Alcohol: During early experience with this drug, it was thought advisable for each patient to have at least 1 supervised alcohol-drug reaction. More recently, the test reaction has been largely abandoned. Such a test reaction should never be administered to a patient over 50 years of age. A clear, detailed and convincing description of the reaction is felt to be sufficient in most cases. However, where a test reaction is deemed necessary, the suggested procedure is outlined in the manufacturer product information.
  • In severe reactions, whether caused by an excessive test dose or by the patient's unsupervised ingestion of alcohol, supportive measures to restore blood pressure and treat shock should be instituted. Other recommendations include: oxygen, carbogen (95% oxygen and 5% carbon dioxide), vitamin C IV in massive doses (1 g) and ephedrine sulfate. IV antihistamines have also been used. Potassium levels should be monitored, particularly in patients on digitalis, since hypokalemia has been reported.
  • It is recommended that treatment should be initiated only in a hospital or specialized clinic and by physicians experienced in its use. The patient should have adequate social and family support to avoid ingestion of alcohol. Suitable patients should not have ingested alcohol for at least 24 hours and must be warned that a disulfiram-alcohol reaction is potentially dangerous.
  • This drug should never be administered to a patient who is under the state of alcohol intoxication, or without the patient's full knowledge. Patients should be thoroughly educated, along with their relatives, about the reaction between this drug and alcohol.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by